Liver Cancer
New findings in the area of liver cancer detailed
Published in Hepatitis Weekly, June 6th, 2005
Study 1: Aberrant Pim-3 expression encourages hepatocellular carcinoma proliferation.
"Most cases of human hepatocellular carcinoma develop after persistent chronic infection with human hepatitis B virus or hepatitis C virus, and host responses are presumed to have major roles in this process. To recapitulate this process, we have developed the mouse model of hepatocellular carcinoma using hepatitis B virus surface antigen transgenic mice," scientists in Japan report.
"To identify the genes associated with hepatocarcinogenesis in this model, we compared the...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2005-06-06)
More Articles from Hepatitis Weekly
- Cancer Prevention
Coffee consumption may lower one's risk for developing liver cancer - Immunization
Double dose hepatitis B vaccine protects HIV-infected adult patients - Transplant Medicine
Extrahepatic compartments contribute HCV circulation during liver transplants - Vaccine Development
Recombinant vaccine antigen protects monkeys against hepatitis E infection - Virology
Patients with occult hepatitis C may be able to infect others - Addiction Medicine
Antidepressant prophylaxis benefits HCV-positive drug users on interferon - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
